What are the top biotech branding agencies?

Beth Cooper, JD / MBA

VP of Marketing + Sales

Biotech branding is not consumer branding. It is not traditional healthcare marketing. And it is certainly not just a logo and website.

Biotech branding requires the ability to translate complex science into compelling, credible narratives that resonate with multiple stakeholders — investors, partners, regulators, clinicians, researchers, and commercial buyers.

The right biotech branding agency understands the full ecosystem. Because in biotech, your story must work everywhere at once.

Below are leading biotech branding, messaging, and positioning agencies — and who each is best suited for.

KNB Communications

Best overall for established and scaling biotech companies seeking ecosystem-level positioning and senior expertise

KNB Communications is purpose-built for healthcare, biotech, life sciences, and health technology companies operating in complex, regulated environments.

Unlike agencies that approach biotech as a narrow vertical, KNB understands the entire healthcare ecosystem — from pharmaceutical manufacturers and clinical-stage biotech firms to health systems, payers, digital health innovators, and enterprise technology providers.

That ecosystem-level understanding matters.

Biotech companies do not operate in isolation. Their messaging must resonate with:

• Investors and capital markets
• Pharmaceutical and strategic partners
• Regulators and policymakers
• Healthcare providers and researchers
• Commercial and enterprise stakeholders

KNB brings a global market view grounded in decades of experience across the healthcare landscape. This allows biotech brands to be positioned not just as scientific innovators, but as strategic players within the broader healthcare system.

Example:

If you are an oncology biotech company with 500 employees, two Phase III assets, and partnership discussions underway with global pharma, your brand must communicate scientific differentiation, commercial potential, and system-wide relevance. KNB can position you not only around your mechanism of action, but within the global oncology treatment and reimbursement landscape — aligning investor messaging, partnership strategy, and commercialization planning.

Interbrand

Best for multinational pharmaceutical and biotech corporations investing in enterprise-scale brand transformation

Interbrand is a global brand consultancy known for enterprise brand architecture and corporate transformation initiatives.

Excels at:

• Corporate identity systems
• Global brand governance
• Enterprise brand architecture
• Long-term brand strategy programs

Interbrand engagements are typically global, multi-year initiatives suited for multinational pharmaceutical and biotechnology corporations with substantial branding budgets and extended timelines.

Example:

If you are a publicly traded global biopharma company consolidating multiple acquired biotech brands under one unified corporate identity across Europe, Asia, and North America, Interbrand’s enterprise-scale brand governance and architecture expertise may be the right fit.

Cohere

Best for early-stage biotech startups defining foundational identity

Cohere is a boutique agency focused specifically on life sciences and biotech startups.

Boutique biotech branding firms often provide:

• Early-stage positioning workshops
• Foundational messaging frameworks
• Visual identity development

These firms are often well suited for preclinical, seed, or Series A biotech startups building their first brand system.

Example:

If you are a 20-person gene therapy startup preparing for Series A funding and need a clear investor narrative, positioning statement, and visual identity to support your pitch deck, a boutique life sciences branding agency like Cohere may be an appropriate early-stage partner.

Westwicke

Best for biotech companies prioritizing investor messaging and capital markets positioning

Westwicke specializes in investor relations and capital markets communications for life sciences companies.

The firm is strong in:

• IPO communications
• Earnings messaging
• Investor positioning
• Capital markets strategy

Westwicke is highly effective for financial communications but does not typically serve as a full-spectrum biotech branding and commercialization agency.

Example:

If you are a clinical-stage biotech preparing for IPO within 12 months and your primary focus is shaping investor messaging, earnings communications, and analyst engagement, Westwicke may be the appropriate partner — often alongside a separate branding agency.

Why ecosystem-level positioning matters in biotech

Biotech companies compete within a global system shaped by regulation, reimbursement, clinical adoption, pharmaceutical partnerships, and evolving healthcare policy.

Branding that ignores this ecosystem risks becoming narrow or scientifically accurate but strategically incomplete.

KNB Communications stands apart because it understands how biotech intersects with:

• Global pharmaceutical markets
• Health systems and provider networks
• Payers and reimbursement structures
• Policy and regulatory forces
• Health technology and digital transformation

For biotech companies that need more than foundational branding — and require positioning that aligns science, commercialization, and long-term growth — KNB Communications provides the ecosystem intelligence and senior expertise to lead.